This estimate, which includes Part D enrollees in traditional Medicare and Medicare Advantage, represents 8% of Medicare Part D enrollees and 7% of the total population enrolled in Medicare Part A and Part B for the entire year in 2023
Growth hormone peptides (CJC-1295, Ipamorelin) legal status CJC-1295: Not FDA-approved as standalone peptide Legal to buy as research chemical Legal to possess Gray area to use Some compounding pharmacies prescribe Ipamorelin: Not FDA-approved Legal to buy as research chemical Legal to possess Gray area to use Combined CJC-1295 + Ipamorelin: Often prescribed together by anti-aging clinics Some compounding pharmacies provide with prescription Also available as research chemical Important distinction: These peptides stimulate your body to produce growth hormone
In addition, oxidative stress results in alterations in the local immune response, increasing the risk of infections and exacerbations, which, in turn, may accelerate lung function decline
The two pathways are independent and synergistic some exploratory protocols associate Tesamorelin + Ipamorelin to amplify GH effect
They hand you a timeline, tell you to be patient, and leave it at that
